Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axillary Hyperhidrosis in Children (AICHI) Study
jRCT1041230174Active, not recruiting
- Sponsor
- Kaken Pharmaceutical Co., Ltd.
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sofpironium in essential axillary hyperhidrosis, sponsored by Kaken Pharmaceutical Co., Ltd. Primary endpoint: Proportion of patients with HDSS score 1 or 2 at Weeks 2 and 4. Started Mar 2024; status: active, not recruiting.
02
Drugs
sofpironium
03
Conditions
essential axillary hyperhidrosis
Beyond the preview
Go deeper on jRCT1041230174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041230174.